Pembrolizumab for Early Triple-Negative Breast Cancer

被引：19
|
作者：
Cetin, Bulent [1 ]
Gumusay, Ozge [2 ]
机构：
[1] Suleyman Demirel Univ, Isparta, Turkey
[2] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2020年 / 382卷 / 26期
关键词：
D O I：
10.1056/NEJMc2006684
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Pembrolizumab for Early Triple-Negative Breast Cancer
    Schmid, Peter
    Cortes, Javier
    Pusztai, Lajos
    McArthur, Heather
    Kuemmel, Sherko
    Bergh, Jonas
    Denkert, Carsten
    Park, Yeon Hee
    Hui, Rina
    Harbeck, Nadia
    Takahashi, Masato
    Foukakis, Theodoros
    Fasching, Peter A.
    Cardoso, Fatima
    Untch, Michael
    Jia, Liyi
    Karantza, Vassiliki
    Zhao, Jing
    Aktan, Gursel
    Dent, Rebecca
    O'Shaughnessy, Joyce
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (09): : 810 - 821
  • [2] Pembrolizumab in Early Triple-Negative Breast Cancer
    Ganguly, Shuvadeep
    Gogia, Ajay
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (18): : 1771 - 1771
  • [3] Pembrolizumab for Early Triple-Negative Breast Cancer Reply
    Schmid, Peter
    Dent, Rebecca
    O'Shaughnessy, Joyce
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (26):
  • [4] Pembrolizumab in Triple-Negative Breast Cancer
    Sun, Ryan
    Wei, Lee-Jen
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (15): : 1435 - 1435
  • [5] Pembrolizumab for triple-negative breast cancer
    Stirrups, Robert
    [J]. LANCET ONCOLOGY, 2020, 21 (04): : E183 - E183
  • [6] Pembrolizumab in the neoadjuvant Treatment of early triple-negative Breast Cancer
    Dierks, Friederike
    Pietsch, Elisabeth
    Dunst, Juergen
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (09) : 841 - 843
  • [7] Pembrolizumab and atezolizumab in triple-negative breast cancer
    Kwapisz, Dorota
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (03) : 607 - 617
  • [8] Pembrolizumab and atezolizumab in triple-negative breast cancer
    Dorota Kwapisz
    [J]. Cancer Immunology, Immunotherapy, 2021, 70 : 607 - 617
  • [9] Pembrolizumab in Triple-Negative Breast Cancer Reply
    Cortes, Javier
    Zhou, Xuan
    Schmid, Peter
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (15): : 1436 - 1436
  • [10] Pembrolizumab monotherapy in metastatic triple-negative breast cancer
    Amir, Eitan
    Cescon, David W.
    [J]. LANCET ONCOLOGY, 2021, 22 (04): : 415 - 417
12345